Ortiz-Guzmán Johan E, Mollà-Casanova Sara, Arias-Mutis Óscar J, Bizy Alexandra, Calvo Conrado, Alberola Antonio, Chorro Francisco J, Zarzoso Manuel
Department of Physiology, Universitat de València, 46010 Valencia, Spain.
UBIC Research Group, Department of Physiotherapy, Universitat de València, 46010 Valencia, Spain.
J Cardiovasc Dev Dis. 2023 May 9;10(5):203. doi: 10.3390/jcdd10050203.
Our aim was to determine the impact that metabolic syndrome (MS) produces in long-term heart rate variability (HRV), quantitatively synthesizing the results of published studies to characterize the cardiac autonomic dysfunction in MS.
We searched electronic databases for original research works with long-term HRV recordings (24 h) that compared people with MS (MS+) versus healthy people as a control group (MS-). This systematic review and meta-analysis (MA) was performed according to PRISMA guidelines and registered at PROSPERO (CRD42022358975).
A total of 13 articles were included in the qualitative synthesis, and 7 of them met the required criteria to be included in the MA. SDNN (-0.33 [-0.57, 0.09], = 0.008), LF (-0.32 [-0.41, -0.23], < 0.00001), VLF (-0.21 [-0.31, -0.10], = 0.0001) and TP (-0.20 [-0.33, -0.07], = 0.002) decreased in patients with MS. The rMSSD ( = 0.41), HF ( = 0.06) and LF/HF ratio ( = 0.64) were not modified.
In long-term recordings (24 h), SDNN, LF, VLF and TP were consistently decreased in patients with MS. Other parameters that could be included in the quantitative analysis were not modified in MS+ patients (rMSSD, HF, ratio LF/HF). Regarding non-linear analyses, the results are not conclusive due to the low number of datasets found, which prevented us from conducting an MA.
我们的目的是确定代谢综合征(MS)对长期心率变异性(HRV)产生的影响,通过定量综合已发表研究的结果来描述MS中的心脏自主神经功能障碍。
我们在电子数据库中搜索了具有长期HRV记录(24小时)的原始研究,这些研究比较了MS患者(MS+)与作为对照组的健康人(MS-)。本系统评价和荟萃分析(MA)按照PRISMA指南进行,并在PROSPERO(CRD42022358975)注册。
定性综合共纳入13篇文章,其中7篇符合纳入MA的要求标准。MS患者的SDNN(-0.33 [-0.57, 0.09],P = 0.008)、LF(-0.32 [-0.41, -0.23],P < 0.00001)、VLF(-0.21 [-0.31, -0.10],P = 0.0001)和TP(-0.20 [-0.33, -0.07],P = 0.002)降低。rMSSD(P = 0.41)、HF(P = 0.06)和LF/HF比值(P = 0.64)未改变。
在长期记录(24小时)中,MS患者的SDNN、LF、VLF和TP持续降低。MS+患者中可纳入定量分析的其他参数未改变(rMSSD、HF、LF/HF比值)。关于非线性分析方面,由于发现的数据集数量较少,结果尚无定论,这使得我们无法进行MA。